Genomic and Proteomic Analyses of Apoptosis Mechanisms in Diseased Peri-implant Tissue

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

September 1, 2024

Conditions
ApoptosisApoptosis Regulatory ProteinsProteasesPeri-Implantitis and Peri-implant Mucositis
Interventions
PROCEDURE

Non-Surgical Intervention

For non-surgical treatment of peri-implant mucositis, granulation tissues were removed by titanium curettes (Hu-Friedy, Titanium Implant Scaler Mini-Five, Chicago, IL, USA) during mechanical debridement under local anesthesia

PROCEDURE

Surgical peri-implant therapy

In cases requiring surgical intervention for peri-implantitis, mucoperiosteal flaps were elevated on both vestibular and oral aspects after administration of local anesthesia (articaine with epinephrine 1:200,000) to expose the peri-implant defect. Granulation tissue from the bony defect area was meticulously excised using by titanium curettes (Hu-Friedy, Titanium Implant Scaler Mini-Five, Chicago, IL, USA).

PROCEDURE

Second stage surgery

Healthy peri-implant mucosa samples were obtained during the second-stage surgery of implant placement procedures. These samples consisted of incisional biopsies of peri-implant mucosa in direct contact with the implant surface.

Trial Locations (1)

54100

Sakarya University, Sakarya

All Listed Sponsors
collaborator

University of Turku

OTHER

collaborator

University of Helsinki

OTHER

lead

Sakarya University

OTHER

NCT06865976 - Genomic and Proteomic Analyses of Apoptosis Mechanisms in Diseased Peri-implant Tissue | Biotech Hunter | Biotech Hunter